Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the software maker’s stock.

Veradigm Stock Performance

MDRX stock opened at $9.25 on Wednesday. Veradigm has a 52 week low of $5.01 and a 52 week high of $13.69. The company’s 50-day simple moving average is $9.59 and its 200 day simple moving average is $9.06.

Institutional Investors Weigh In On Veradigm

Institutional investors have recently made changes to their positions in the stock. Innealta Capital LLC acquired a new position in Veradigm in the 2nd quarter valued at $38,000. Meadow Creek Wealth Advisors LLC acquired a new position in Veradigm in the first quarter valued at about $83,000. Tyro Capital Management LLC bought a new stake in Veradigm during the first quarter worth about $9,055,000. Goldman Sachs Group Inc. lifted its position in Veradigm by 6.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after purchasing an additional 99,528 shares during the period. Finally, Wellington Management Group LLP grew its stake in Veradigm by 117.8% during the fourth quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after buying an additional 3,140,483 shares in the last quarter.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.